Join Our Mailing List:
 
Follow Us:
Shop Contact Us
You have 0  Item in Cart | View Cart
310-841-2600
Featured Events
Sunday, October 15
8th Annual STOP CANCER 5|10K Run|Walk
On your mark, get set, go! Be part of the 8th Annual 5|10K Run|Walk ... More
View All Events
Dinesh Rao, M.D., Ph.D.
Research performed at: UCLA's Jonsson Comprehensive Cancer Center
Specialty/Research Area: Leukemia, Lymphoma
Award Year: 2017
Career Summary: Dinesh S. Rao received a B.S. summa cum laude in Biochemistry and an M.D. from Case Western Reserve University, Cleveland, USA. During this time he developed a deep interest in the pathogenesis of cancer, completing several projects in cancer research during medical school, and went on to a research fellowship at the University of Michigan. There, he made a seminal discovery implicating clathrin mediated trafficking of growth factor receptor tyrosine kinases in the pathogenesis of oncogenic transformation. He then combined clinical training in the pathology of hematologic diseases with further research training in the laboratory of Nobel laureate David Baltimore at Caltech. His research came to focus on the involvement of microRNAs in hematologic development, particularly B-cell development and immunity, and cancer, and resulted in several high-impact publications in well-regarded journals. His research interests include how novel elements of gene expression regulation control hematopoietic development and cancer. He combines running a vibrant research laboratory with a busy diagnostic service in leukemia and lymphoma pathology.
 
Year STOP CANCER Award received: 2017 Barbara and Gary Luboff Mitzvah Fund Seed Grant 

Description of research performed: Dinesh Rao and his laboratory are dedicated to the study of leukemia and lymphoma.  In the past few years, this research has come to focus on certain cellular proteins and other elements that are highly expressed in aggressive subtypes of childhood acute lymphoblastic leukemia.  In addition to understanding how normal cells of the blood system turn into cancer, the laboratory is focused on understanding how to use this knowledge in the clinical care of cancer patients.

 

STOP CANCER is committed to funding the most promising and innovative scientists in their early research of all forms of cancer prevention, treatment, cures and subsequent clinical applications. STOP CANCER works primarily with local National Cancer Institute-designated Comprehensive Cancer Centers and other qualified institutions in the United States to carry out its mission.

Copyright © 2017 STOP CANCER. All Rights Reserved. | Privacy Policy